{"nct_id":"NCT03978520","title":"A Study to Investigate the Safety and Efficacy of Elsubrutinib and Upadacitinib Given Alone or in Combination in Participants With Moderately to Severely Active Systemic Lupus Erythematosus (SLE)","status":"COMPLETED","status_verified_date":"2023-06","start_date":"2019-07-25","start_date_type":"ACTUAL","primary_completion_date":"2022-01-19","primary_completion_date_type":"ACTUAL","completion_date":"2022-07-14","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["ABBV"]}